Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions

Autor: Faisal Abaalkhail, Almoataz Hashim, Nathalie Bassil, Mohamed Safwat, Abdulrahman Aljumah, Faisal M. Sanai, Mohamed A. Babatin

Publikováno v: The Saudi Journal of Gastroenterology, Vol 25, Iss 2, Pp 73-80 (2019)
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association

Hepatitis B virus (HBV) infection remains a public health problem worldwide. In this review, we aim to assess the current situation of the HBV care pathway in the Kingdom of Saudi Arabia (KSA), identify gaps/barriers therein, and recommend initiative

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14736170448f4ac74029080727d6b14b
http://www.saudijgastro.com/article.asp?issn=1319-3767

Analysis of Hepatitis B virus (HBV) mutations in patients from Western Saudi Arabia with chronic disease

Autor: Noura A. Othman, Mohamed Abdel-Hamid, Mohammed Abdullah Alsaedi, Mohamed A. Babatin, Abdullah Saeed Alghamdi, Tagreed L. Alsubhi, Hisham Othman Akbar, Ghazi Abdulatif Jamjoom, Yousef Qari, Esam I. Azhar, Sherif A. El-Kafrawy, Mai M. El-Daly, Hind I Fallatah

Publikováno v: The Journal of Infection in Developing Countries. 12:557-567

Introduction: Extensive research has provided a link between HBV variants and the clinical complications of liver diseases. This study was performed to further investigate the relationship between HBV variants in preS, S and BCP/PC regions and diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::050ecffb68dd50a737303c8793a9f355
https://doi.org/10.3855/jidc.9534

High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease

Autor: Abdullah S. Alghamdi, Adnan AlZanbagi, Mohammed Aseeri, Khalid Alswat, Mohamed A. Babatin, Abdallah AlMousa, Mosfer N. Alghamdi, Abdullah M. Assiri, Ahmad A. Afghani, Faisal M. Sanai

Publikováno v: Liver International. 38:1395-1401

BACKGROUND & AIMS Limited data have shown high efficacy of co-formulated ombitasvir/paritaprevir/ritonavir (OBV/PTV/r) in the treatment of hepatitis C virus (HCV) genotype (GT)-4, and combined with dasabuvir (DSV) in GT1 patients, with chronic kidney

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e39fe45543bafe7645c332dd3a54ebb
https://doi.org/10.1111/liv.13674

Epidemiology, Disease Burden, and Treatment Strategies of Chronic Hepatitis C Virus Infections in Saudi Arabia in the New Treatment Paradigm Shift

Autor: Homie Razavi, Abdullah S. Alghamdi, Hamad I. Al-Ashgar, Raafat F. Alhakeem, Ibrahim Altraif, Almoataz Hashim, Adel Alqutub, Faisal Abaalkhail, Mohamed A. Babatin, Faleh Z. Al Faleh, Faisal M. Sanai, Jonathan Schmelzer, Khalid Alswat, Abdulrahman Aljumah, Abdullah M. Assiri

Publikováno v: Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association
The Saudi Journal of Gastroenterology, Vol 22, Iss 4, Pp 269-281 (2016)

Background/Aims: Around 101,000 individuals are estimated to be viremic for chronic hepatitis C virus (HCV) in the Kingdom of Saudi Arabia (KSA) in 2014; however, only about 20% have been diagnosed. We aim to assess baseline epidemiology, disease bur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8656edde059e3fcd9e2fde89db438a6
http://europepmc.org/articles/PMC4991197

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Autor: Altaf Alam, K. Saeed, N. Nugrahini, Fadi H. Mourad, Andri Sanityoso Sulaiman, Abdul Rahman Bizri, Jon G. Jonasson, Liana Gheorghe, S. Alawadhi, Ala I. Sharara, Sarah Blach, Rino Alvani Gani, Do Young Kim, M. Alzaabi, Young Seok Kim, Matti Maimets, S. Priohutomo, A. Löve, Saeed Hamid, Abdullah M. Assiri, H. Al Quraishi, Adel Alqutub, G. Tayyab, Junko Tanaka, H. Qureshi, A. Salamat, P. Aldins, M. S. Choi, M. T. Barakat, Reza Malekzadeh, M. Sadik, Kwang Hyub Han, Young-Suk Lim, J. Videčnik-Zorman, A. Abdou, Jacques E Mokhbat, Zaigham Abbas, Khalid Alswat, G. Sigmundsdottir, B. Karlsdottir, Marwa Sultan, K. Al Jaberi, Devin Razavi-Shearer, A. Al Rifai, Chris Estes, Abdullah S. Alghamdi, A. Sanityoso Sulaiman, Béla Hunyady, F. Al Braiki, B. Sigurdardottir, Ieva Tolmane, Kathryn Razavi-Shearer, S. El Khoury, Gabor Horvath, Y. Al Serkal, M. Taha, Hamad I. Al-Ashgar, Cesar Yaghi, Abdulrahman Aljumah, Danute Speiciene, Riina Salupere, Irsan Hasan, S. Fakhry, Homie Razavi, Evy Yunihastuti, F. Al Hosani, M. A. Al Mulla, Faisal M. Sanai, Mohamed A. Babatin, N. Andrea, L. Al-Dabal, S. Gregorcic, Arif Nawaz, R. Al-Hakeem, E. S. El Hassan, R. Husni, M. Siddiq, David H. Muljono, Adrian Goldis, A. Almessabi, Jonathan Schmelzer, Mojca Maticic, Laurentius A. Lesmana, A. Baqir, Ibrahim Altraif, Faisal Abaalkhail, Shahin Merat, Mihály Makara, A. Abourached, Jonas Valantinas, Asad Chaudhry, T. Diab, M. Ud Din, Muhammad S. Memon, Jessie Gunter, R. A. Sayegh, Seyed Moayed Alavian, A. M. Siddiqui, H. Fridjonsdottir, Bader Faiyaz Zuberi, M. Umar, Magnus Gottfredsson, Baiba Rozentale, Agita Jeruma, Samsuridjal Djauzi, Almoutaz Hashim, A. Ghafoor Khan, Ottar M. Bergmann, Z. Koutoubi, M. A. Yusuf, H. Tarifi, A. Sibley, Faleh Z. Al-Faleh, Wasim Jafri, P. Rassam, J. I. Farooqi, S. Olafsson, Behzad Hajarizadeh, Valentina Liakina, M. Al Khatry

Publikováno v: Journal of viral hepatitis
Razavi, H, Waked, I, Sarrazin, C, Myers, R P, Idilman, R, Calinas, F, Vogel, W, Mendes Correa, M C, Hézode, C, Lázaro, P, Akarca, U, Aleman, S, Balık, I, Berg, T, Bihl, F, Bilodeau, M, Blasco, A J, Brandão Mello, C E, Bruggmann, P, Buti, M, Calleja, J L, Cheinquer, H, Christensen, P B, Clausen, M, Coelho, H S M, Cramp, M E, Dore, G J, Doss, W, Duberg, A S, El-Sayed, M H, Ergör, G, Esmat, G, Falconer, K, Félix, J, Ferraz, M L G, Ferreira, P R, Frankova, S, García-Samaniego, J, Gerstoft, J, Giria, J A, Gonçales, F L, Gower, E, Gschwantler, M, Guimarães Pessôa, M, Hindman, S J, Hofer, H, Husa, P, Kåberg, M, Kaita, K D E, Kautz, A, Kaymakoglu, S, Krajden, M, Krarup, H, Laleman, W, Lavanchy, D, Marinho, R T, Marotta, P, Mauss, S, Moreno, C, Murphy, K, Negro, F, Nemecek, V, Örmeci, N, Øvrehus, A L H, Parkes, J, Pasini, K, Peltekian, K M, Ramji, A, Reis, N, Roberts, S K, Rosenberg, W M, Roudot-Thoraval, F, Ryder, S D, Sarmento-Castro, R, Semela, D, Sherman, M, Shiha, G E, Sievert, W, Sperl, J, Stärkel, P, Stauber, R E, Thompson, A J, Urbanek, P, Van Damme, P, van Thiel, I, Van Vlierberghe, H, Vandijck, D, Wedemeyer, H, Weis, N, Wiegand, J, Yosry, A, Zekry, A, Cornberg, M, Müllhaupt, B & Estes, C 2014, ' The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm ', Journal of Viral Hepatitis, vol. 21, no. Suppl 1, pp. 34-59 . https://doi.org/10.1111/jvh.12248
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Razavi, H, Waked, I, Sarrazin, C, Myers, R P, Idilman, R, Calinas, F, Vogel, W, Mendes Correa, M C, Hézode, C, Lázaro, P, Akarca, U, Aleman, S, Balık, I, Berg, T, Bihl, F, Bilodeau, M, Blasco, A J, Brandão Mello, C E, Bruggmann, P, Buti, M, Calleja, J L, Cheinquer, H, Christensen, P B, Clausen, M, Coelho, H S M, Cramp, M E, Dore, G J, Doss, W, Duberg, A S, El-Sayed, M H, Ergör, G, Esmat, G, Falconer, K, Félix, J, Ferraz, M L G, Ferreira, P R, Frankova, S, García-Samaniego, J, Gerstoft, J, Giria, J A, Gonçales, F L, Gower, E, Gschwantler, M, Guimarães Pessôa, M, Hindman, S J, Hofer, H, Husa, P, Kåberg, M, Kaita, K D E, Kautz, A, Kaymakoglu, S, Krajden, M, Krarup, H, Laleman, W, Lavanchy, D, Marinho, R T, Marotta, P, Mauss, S, Moreno, C, Murphy, K, Negro, F, Nemecek, V, Örmeci, N, Holm, A L, Parkes, J, Pasini, K, Peltekian, K M, Ramji, A, Reis, N, Roberts, S K, Rosenberg, W M, Roudot-Thoraval, F, Ryder, S D, Sarmento-Castro, R, Semela, D, Sherman, M, Shiha, G E, Sievert, W, Sperl, J, Stärkel, P, Stauber, R E, Thompson, A J, Urbanek, P, Van Damme, P, van Thiel, I, Van Vlierberghe, H, Vandijck, D, Wedemeyer, H, Weis, N, Wiegand, J, Yosry, A, Zekry, A, Cornberg, M, Müllhaupt, B & Estes, C 2014, ' The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm ', Journal of Viral Hepatitis, vol. 21, no. Suppl 1, pp. 34–59 . https://doi.org/10.1111/jvh.12248
Journal of Viral Hepatitis, Vol. 21 Suppl 1 (2014) pp. 34-59

Gilead Sciences The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modelling approach was used to estimate the total number of viremic infections, diagnosed, treated and new infections in 2013. in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ebbc6a8b2a97eb03fc96aa66e20346a
https://hdl.handle.net/10067/1171300151162165141